PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner

[1]  Baris Turkbey,et al.  Review of functional/anatomical imaging in oncology , 2012, Nuclear medicine communications.

[2]  N. F. Schwenzer,et al.  Whole-body MR/PET: applications in abdominal imaging , 2012, Abdominal Imaging.

[3]  G. Delso,et al.  Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner , 2011, The Journal of Nuclear Medicine.

[4]  D. Körholz,et al.  Die Bedeutung des FDG-PET für die Stadieneinteilung und Therapie des Hodgkin-Lymphoms im Kindesalter , 2011, Klinische Pädiatrie.

[5]  Paul S Babyn,et al.  Whole-body MR imaging in children: principles, technique, current applications, and future directions. , 2011, Radiographics : a review publication of the Radiological Society of North America, Inc.

[6]  H. Amthauer,et al.  [18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Ilja Bezrukov,et al.  MRI-Based Attenuation Correction for Whole-Body PET/MRI: Quantitative Evaluation of Segmentation- and Atlas-Based Methods , 2011, The Journal of Nuclear Medicine.

[8]  Frederic H. Fahey,et al.  Minimizing and Communicating Radiation Risk in Pediatric Nuclear Medicine , 2011, The Journal of Nuclear Medicine.

[9]  P. Bartenstein,et al.  123I-MIBG scintigraphy/SPECT versus 18F-FDG PET in paediatric neuroblastoma , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  Ernst J. Rummeny,et al.  Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  M. Gaze,et al.  18F-FDG PET/CT and 123I-Metaiodobenzylguanidine Imaging in High-Risk Neuroblastoma: Diagnostic Comparison and Survival Analysis , 2011, The Journal of Nuclear Medicine.

[12]  R. Kluge,et al.  [Role of FDG-PET in Staging and Therapy of Children with Hodgkin Lymphoma]. , 2011, Klinische Padiatrie.

[13]  Bernd J Pichler,et al.  Combined PET/MRI: one step further in multimodality imaging. , 2010, Trends in molecular medicine.

[14]  Thomas C. Kwee,et al.  Whole-body diffusion-weighted imaging for staging malignant lymphoma in children , 2010, Pediatric Radiology.

[15]  H. Amthauer,et al.  [Procedure guidelines for whole-body 18F-FDG PET and PET/CT in children with malignant diseases]. , 2010, Nuklearmedizin. Nuclear medicine.

[16]  R. Kluge,et al.  Whole-body MRI for primary evaluation of malignant disease in children. , 2010, European journal of radiology.

[17]  Heinz-Peter Schlemmer,et al.  PET/MRI: Paving the Way for the Next Generation of Clinical Multimodality Imaging Applications , 2010, Journal of Nuclear Medicine.

[18]  K. Hahn,et al.  Empfehlungen zur Durchführung der Ganz körper-18F-FDG-PET und -PET/CT bei Kindern mit onkologischen Erkrankungen , 2010, Nuklearmedizin.

[19]  Cyrill Burger,et al.  Integrating imaging modalities: what makes sense from a workflow perspective? , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  M. Ines Boechat,et al.  Estimated cumulative radiation dose from PET/CT in children with malignancies: a 5-year retrospective review , 2009, Pediatric Radiology.

[21]  S. Matsumoto,et al.  Detection of bone metastases in non‐small cell lung cancer patients: Comparison of whole‐body diffusion‐weighted imaging (DWI), whole‐body MR imaging without and with DWI, whole‐body FDG‐PET/CT, and bone scintigraphy , 2009, Journal of magnetic resonance imaging : JMRI.

[22]  Molecular imaging with positron emission tomography in paediatric oncology—FDG and beyond , 2009, Pediatric Radiology.

[23]  B. Pichler,et al.  Pre-clinical PET/MR: technological advances and new perspectives in biomedical research , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  Dana Weber,et al.  MRI of the lungs in children. , 2008, European journal of radiology.

[25]  W. Heiss,et al.  An integrated MR/PET system: prospective applications , 2008, Abdominal Imaging.

[26]  H. Amthauer,et al.  Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[27]  D. Brenner,et al.  Cancer risks from diagnostic radiology. , 2008, The British journal of radiology.

[28]  D. Yeung,et al.  Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. , 2007, Radiology.

[29]  H. Jadvar,et al.  PET and PET/CT in pediatric oncology. , 2007, Seminars in nuclear medicine.

[30]  Y. Tsushima,et al.  Body diffusion-weighted MR imaging using high b-value for malignant tumor screening: usefulness and necessity of referring to T2-weighted images and creating fusion images. , 2007, Academic radiology.

[31]  Sigrid Stroobants,et al.  Revised response criteria for malignant lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  David J. Brenner,et al.  Estimating radiation-induced cancer risks at very low doses: rationale for using a linear no-threshold approach , 2006, Radiation and environmental biophysics.

[33]  H. Goo,et al.  Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods , 2005, Pediatric Radiology.

[34]  T. Takahara,et al.  Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. , 2004, Radiation medicine.

[35]  J. Debatin,et al.  Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. , 2003, JAMA.